COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,220 Articles (22,733 medRxiv, 8,487 bioRxiv)

Most recent first Previous |  Page 228: Articles 2271-2280  | Next

Evaluating biomedical feature fusion on machine learning's predictability and interpretability of COVID-19 severity types
West-Page, H. N., McGoff, K., Latimer, H., Olufadewa, I., Chen, S.
10.1101/2024.04.04.24305295 — Posted: 2024-04-05
Increased fibrinaloid microclot counts in platelet-poor plasma are associated with Long COVID
Dalton, C. F., de Oliveira, M. I., Stafford, P., Peake, N., Kane, B., Higham, A., Singh, D., Jackson, N., Davies, H., Price, D., Duncan, R., Tattersall, N., Barnes, A., Smith, D. P.
10.1101/2024.04.04.24305318 — Posted: 2024-04-05
Similarities between long COVID and cognitive impairment and potential implications; Results from the 2022 BRFSS
Adams, M., Grandpre, J.
10.1101/2024.04.02.24305215 — Posted: 2024-04-05
Can self-testing be enhanced to hasten safe return of healthcare workers in pandemics? Random order, open label trial using two manufacturers' SARS-CoV-2 lateral flow devices concurrently
Zhang, X., Cheyne, C. P., Jones, C., Humann, M., Leeming, G., Smith, C., Hughes, D. M., Burnside, G., Dodd, S., Penrice-Randal, R., Dong, X., Semple, M. G., Neal, T., Tunkel, S., Fowler, T., Turtle, L., Garcia-Finana, M., Buchan, I. E.
10.1101/2024.04.04.24305332 — Posted: 2024-04-05
Trust and transfer during the covid-19 pandemic: did digital cash transfer save lives?
Tampubolon, G.
10.1101/2024.04.04.24305360 — Posted: 2024-04-05
Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individuals.
Moreno Echevarria, F., Caputo, M., Reddy, S., Camp, D., Achenbach, C.
10.1101/2024.04.03.24305293 — Posted: 2024-04-05
Multi-ancestry GWAS of diarrhea during acute SARS-CoV2 infection identifies multiple novel loci and contrasting etiological roles of irritable bowel syndrome subtypes
Chaudhary, N. S., Weldon, C. H., Nandakumar, P., Shelton, J., 23andMe Research Team, , Holmes, M. V., Aslibekyan, S.
10.1101/2024.04.03.24305274 — Posted: 2024-04-04
Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19
Canderan, G., Muehling, L., Kadl, A., Ladd, S., Bonham, C., Cross, C., Lima, S., Yin, X., Sturek, J., Wilson, J., Keshavarz, B., Bryant, N., Murphy, D., Cheon, I. S., McNamara, C., Sun, J., Utz, P. J., Dolatshahi, S., Irish, J., Woodfolk, J.
10.1101/2024.04.03.587929 — Posted: 2024-04-04
Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology
Ma, X., Huang, T., Li, X., Zhou, X., Pan, H., Du, A., Zeng, Y., Yuan, K., Wang, Z.
10.1101/2024.04.03.587916 — Posted: 2024-04-04
Within-host genetic diversity of SARS-CoV-2 across animal species
Naderi, S., Sagan, S. M., Shapiro, B. J.
10.1101/2024.04.03.587973 — Posted: 2024-04-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).